-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Biogen with Equal-Weight Rating, Announces Price Target of $185

Benzinga·02/20/2026 14:47:48
Listen to the news
Barclays analyst Emily Field initiates coverage on Biogen (NASDAQ:BIIB) with a Equal-Weight rating and announces Price Target of $185.